Sylogist Stock Price To Earnings To Growth
| SYZLF Stock | USD 6.67 0.27 4.22% |
Fundamental analysis of Sylogist allows traders to better anticipate movements in Sylogist's stock price by examining its financial health and performance throughout various phases of its business cycle.
Sylogist |
Sylogist Company Price To Earnings To Growth Analysis
Sylogist's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Sylogist has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the IT Services sector and about the same as Information Technology (which currently averages 0.0) industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Sylogist Fundamentals
| Return On Equity | 0.0653 | |||
| Return On Asset | 0.0285 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 116.68 M | |||
| Shares Outstanding | 23.92 M | |||
| Shares Owned By Insiders | 4.94 % | |||
| Shares Owned By Institutions | 35.61 % | |||
| Price To Earning | 10.30 X | |||
| Price To Book | 3.45 X | |||
| Price To Sales | 2.00 X | |||
| Revenue | 53.66 M | |||
| Gross Profit | 33.9 M | |||
| EBITDA | 15.25 M | |||
| Net Income | 2.87 M | |||
| Cash And Equivalents | 12.48 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 26.36 M | |||
| Debt To Equity | 0.66 % | |||
| Current Ratio | 0.46 X | |||
| Book Value Per Share | 1.73 X | |||
| Cash Flow From Operations | 13 M | |||
| Earnings Per Share | 0.08 X | |||
| Number Of Employees | 14 | |||
| Beta | 0.68 | |||
| Market Capitalization | 111.84 M | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.01 % | |||
| Last Dividend Paid | 0.5 |
About Sylogist Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sylogist's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sylogist using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sylogist based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sylogist Pink Sheet
Sylogist financial ratios help investors to determine whether Sylogist Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sylogist with respect to the benefits of owning Sylogist security.